TRAVERSA SERGIO
Chief Executive Officer
TRAVERSA SERGIO has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, TRAVERSA SERGIO is listed as Chief Executive Officer at RELMADA THERAPEUTICS, INC. Inside the rolling window, TRAVERSA SERGIO reported 4 open-market purchases totaling $1.5M in RLMD and no open-market sales. The largest disclosed transaction in the window is a purchase of 272,500 RLMD shares on Nov 5, 2025, worth $600K.
Companies traded
Other insiders at RLMD
Insider Buying
$1.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has TRAVERSA SERGIO made?
TRAVERSA SERGIO has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does TRAVERSA SERGIO trade?
TRAVERSA SERGIO has filed SEC Form 4 disclosures for 1 company, including RLMD.
When was TRAVERSA SERGIO's most recent SEC Form 4 filing?
TRAVERSA SERGIO's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is TRAVERSA SERGIO's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, TRAVERSA SERGIO is listed as Chief Executive Officer.
What is TRAVERSA SERGIO's total buy and sell value in the current window?
Inside the rolling retention window, TRAVERSA SERGIO bought $1.5M and sold $0 based on SEC Form 4 filings.
What was TRAVERSA SERGIO's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 272,500 RLMD shares on 2025-11-05, worth $600K, per SEC Form 4 filings.